A borate-functionalized hypoxia-activatable theranostic agent for targeted tumor photo-chemoimmunotherapy.
Hypoxia-activated theranostic agents (HATAs) represent a promising strategy for selective visualization and treatment of hypoxic tumor cells. However, their therapeutic efficacy is restricted by limited tumor-targeting capability, inefficient theranostic agent activation and immunosuppressive microenvironment. Herein,...